FDA reviewing cancer risk with diabetes pill Actos - BusinessWeek

[INCIID News Feed]

Town Hall
<img alt="" height="1" width="1" />
FDA reviewing cancer risk with diabetes pill Actos
BusinessWeek
The Food and Drug Administration is reviewing data suggesting a possible link between the diabetes medication Actos and bladder cancer. The agency says five-year results from an ongoing study show patients taking Actos the longest had higher risk of ...
FDA Reviewing Safety Information On Diabetes Drug ActosWall Street Journal
FDA investigates diabetes drug&#39;s safetyWashington Post
FDA to review Actos for bladder cancer riskDrug Store News
MedPage Today -Reuters India
all 102 news articles &raquo;


More...